the lack of understanding makes an already devastating diagnosis even more overwhelming for them and their families. Friedreich’s ataxia is a rare, progressive neurodegenerative disease that ...

A West Annapolis family has turned two life-altering diagnoses into more than $1 million for research toward finding a cure ...

Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...

Lexeo Therapeutics (LXEO) announced positive interim data across all dose cohorts of LX2006 for the treatment of Friedreich ataxia ...

Friedreich’s ataxia and more general forms of hereditary ataxias. The most common symptoms of the disease "are balance and walking difficulties, clumsiness, vision changes, speech difficulties ...

Lexeo Therapeutics Inc. produced more positive interim data from early stage studies of its gene therapy to treat Friedreich’s ataxia cardiomyopathy. The results have prompted the company to continue ...

Discover how neuroimaging uncovers Friedreich ataxia progression patterns. Learn how biomarkers could transform clinical ...

When he was 19, he was halfway through a tattoo apprenticeship when he was diagnosed with Friedreich's Ataxia (FA)—a degenerative ... 15,000 people globally are affected by its life-altering symptoms.

The firm plans to use improvement in left ventricular mass index and increased frataxin protein expression after LX2006 treatment as co-primary endpoints.

Since reducing oxidative stress and mitochondrial dysfunction rather than reversing Friedreich's ataxia symptoms is the mechanism of action for vatiquinone, the agency might want more long-term ...

Considering taking supplements to treat cerebellar ataxia? Below is a list of common natural remedies used to treat or reduce the symptoms of cerebellar ataxia. Follow the links to read common ...

Ataxia Treatment Market, trends, and advancements in neurological disorder treatments. Discover growth drivers, key players, and forecasts up to 2035 ...